These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 89089)

  • 1. Antigenic specificity of neutralizing antibody to cholera toxin.
    Peterson JW; Hejtmancik KE; Markel DE; Craig JP; Kurosky A
    Infect Immun; 1979 Jun; 24(3):774-9. PubMed ID: 89089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the antigenic determinants of cholera toxin subunits.
    Markel DE; Hejtmancik KE; Peterson JW; Martin FB; Kurosky A
    Infect Immun; 1979 Aug; 25(2):615-26. PubMed ID: 90654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological relationships between cholera toxin and Escherichia coli heat-labile enterotoxin.
    Gilligan PH; Brown JC; Robertson DC
    Infect Immun; 1983 Nov; 42(2):683-91. PubMed ID: 6196292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial and antitoxin responses in the serum and milk of cholera patients.
    Majumdar AS; Dutta P; Dutta D; Ghose AC
    Infect Immun; 1981 Apr; 32(1):1-8. PubMed ID: 7216479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoassay for the antigenic determinants of cholera toxin and its components.
    Hejtmancik KE; Peterson JW; Markel DE; Kurosky A
    Infect Immun; 1977 Sep; 17(3):621-8. PubMed ID: 71268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Titration of cholera antitoxin in human sera by microhemagglutination with formalinized erythrocytes.
    Hochstein HD; Feeley JC; DeWitt WE
    Appl Microbiol; 1970 May; 19(5):742-5. PubMed ID: 5463574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against synthetic peptides of the B subunit of cholera toxin: crossreaction and neutralization of the toxin.
    Jacob CO; Sela M; Arnon R
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7611-5. PubMed ID: 6584874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against experimental cholera by oral or parenteral immunization.
    Peterson JW
    Infect Immun; 1979 Nov; 26(2):594-8. PubMed ID: 546789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of hybridoma cell lines and characterization of monoclonal antibodies against cholera enterotoxin and its subunits.
    Robb M; Nichols JC; Whoriskey SK; Murphy JR
    Infect Immun; 1982 Oct; 38(1):267-72. PubMed ID: 6183210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the antibody composition and neutralizing activity of tetanus antitoxin sera from various species of animals in relation to the antigenic substructure of the tetanus toxin molecule.
    Matsuda M; Makinaga G; Hirai T
    Biken J; 1983 Dec; 26(4):133-43. PubMed ID: 6204634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of polyclonal and monoclonal antibody responses to cholera toxin by the synthetic peptide approach.
    Ghose AC; Karush F
    Mol Immunol; 1988 Mar; 25(3):223-30. PubMed ID: 3374493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitoxic immunity in experimental cholera: protection, and serum and local antibody responses in rabbits after enteral and parenteral immunization.
    Holmgren J; Svennerholm AM; Ouchterlony O; Anderson A; Walletström G; Westerberg-Berndtsson U
    Infect Immun; 1975 Dec; 12(6):1331-40. PubMed ID: 54337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of local IgA antitoxin-producing cells for intestinal protection against cholera toxin challenge.
    Lycke N; Bromander AK; Holmgren J
    Int Arch Allergy Appl Immunol; 1989; 88(3):273-9. PubMed ID: 2785966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local (immunoglobulin A) immune response by the intestine to cholera toxin and its partial suppression with combined systemic and intra-intestinal immunization.
    Yardley JH; Keren DF; Hamilton SR; Brown GD
    Infect Immun; 1978 Feb; 19(2):589-97. PubMed ID: 631891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward the development of a standard reference cholera antitoxin.
    Craig JB
    Dev Biol Stand; 1978; 41():415-22. PubMed ID: 753669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AGGLUTINATING, LETHAL TOXIN AND E1 TOR HAEMOLYSIN NEUTRALIZING POTENCY OF SERA IN CHOLERA.
    FELSENFELD O; NASUNIYA N; WATANABE Y; PENA A; DALE BN
    Bull World Health Organ; 1964; 30(6):833-44. PubMed ID: 14215189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral immunization of dogs with purified cholera toxin, crude cholera toxin, or B subunit: evidence for synergistic protection by antitoxic and antibacterial mechanisms.
    Pierce NF; Cray WC; Sacci JB
    Infect Immun; 1982 Aug; 37(2):687-94. PubMed ID: 6889574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of cholera toxoid in an enzyme-linked immunosorbent assay for antitoxin.
    Cruce DD; Wachsmuth IK; Feeley JC
    Diagn Immunol; 1983; 1(2):87-9. PubMed ID: 6680095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production and characterization of monoclonal antibodies to cholera toxin.
    Remmers EF; Colwell RR; Goldsby RA
    Infect Immun; 1982 Jul; 37(1):70-6. PubMed ID: 6179882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.